Table 2 Summary table showing the socio-demographic characteristics, catatonia symptoms, LZP dosage and outcome of the sampled NS children
Child ID | Age (years) | BMI | WHO-BMI Classification | School attendance | Case classification | Current drug treatment | Catatonia symptoms before treatment | Initial catatonia score | Initial dose of LZP (mg) | Score 60′ after first dose | Repeat dose of LZP | Score 60′ after second dose | Outcome | Side effects |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
CT001 | 15 | 16.44 | Moderate thinness | Never | Head nodding syndrome plus | Sodium valproate | 2, 3, 4, 5, 9 | 17 | 1 | 4 | None | Improved | None | |
CT002 | 18 | 18.66 | Underweight | Dropped out P.4 | Head nodding syndrome | Sodium valproate | 2, 3, 4, 7, 9 | 19 | 1 | 9 | None | Improved | Sedation Seizure (fell down) | |
CT003 | 15 | 15.98 | Severe thinness | Never | Head nodding syndrome plus | Sodium valproate | 1, 3, 4, 5, 7, 8, 10 | 22 | 1 | 2 | None | Improved | None | |
CT004 | 15 | 12.55 | Severe thinness | Dropped out P.3 | Head nodding syndrome plus | Sodium valproate | 2, 3, 4, 5, 9 | 17 | 0.5 | 10 | None | Improved | Focal seizure with automatisms | |
CT005 | 14 | 14.81 | Severe thinness | Never | Head nodding syndrome plus | Sodium valproate | 2, 3, 4, 5, 7, 8, 9 | 24 | 1 | 24 | 2 mg | 4 | Improved | None |
CT006 | 13 | 15.18 | Severe thinness | Dropped out P.3 | Head nodding syndrome | Carbama-zepine | 1, 2, 3, 4, 9 | 15 | 1 | 15 | 2 mg | 15 | No improvement | Sedation |
CT007 | 10 | 13.48 | Severe thinness | In school in P.1 | Head nodding syndrome | Carbama-zepine | 3, 4, 5 | 10 | 0.5 | 10 | 1 mg | 1 | Improved | None |
CT008 | 10 | 12.07 | Severe thinness | Never | Head nodding syndrome plus | Sodium valproate | 2, 3, 4, 5, 8, 9 | 17 | 0.5 | 6 | None | Improved | None | |
CT009 | 14 | 20.48 | Normal | Dropped out P.1 | Head nodding syndrome plus | Sodium valproate | 2, 4, 5, 9 | 8 | 1 | 8 | 2 mg | 14 | No improvement Nodding episode seen | Sedation Seizure (fell down) |
CT010 | 15 | 18.65 | Normal | In school in P.3, demoted from P.6 | Head nodding syndrome | Sodium valproate | 2, 3, 4, 7, 9 | 12 | 1 | 12 | 2 mg | 12 | No improvement | Sedation |
CT011 | 16 | 17.5 | Mild thinness | Never | Head nodding syndrome plus | Carbama-zepine | 1, 3, 4, 5, 8, 9, 10 | 27 | 1 | 27 | 2 mg | 9 | Improved | Sedation |
CT012 | 19 | 15.06 | Severe thinness | Dropped out P.1 | Head nodding syndrome plus | Sodium valproate | 2, 3, 4, 5, 7, 9 | 20 | 1 | 12 | None | Improved | Sedation | |
CT013 | 18 | 13.43 | Severe thinness | Never | Head nodding syndrome plus | Sodium valproate | 2, 3, 4, 5, 7, 8, 9 | 25 | 0.5 | 9 | None | Improved | Sedation | |
CT014 | 13 | 10.36 | Severe thinness | Never | Head nodding syndrome plus | Carbama-zepine | 2, 3, 4, 5, 7, 9 | 20 | 0.5 | 12 | None | Improved | Sedation | |
CT015 | 21 | 16.3 | Moderate thinness | Dropped out P.1 | Head nodding syndrome plus | Carbama-zepine | 1, 2, 3, 4, 7, 9, 10 | 27 | 1 | 13 | None | Improved | Drooling saliva | |
CT016 | 15 | 14.1 | Severe thinness | Dropped out P.2 | Head nodding syndrome plus | Carbama-zepine | 1, 2, 3, 4, 5, 7, 9 | 18 | 1 | 7 | None | Improved | None |
Key for the catatonia symptoms | |
|---|---|
Number | Symptom |
1 | Excitement |
2 | Immobility-stupor |
3 | Mutism |
4 | Staring |
5 | Grimacing |
6 | Echopraxia or echolalia |
7 | Rigidity |
8 | Negativism |
9 | Active or passive refusal to eat or drink |
10 | Impulsivity |